Most Recent

With the arrival of a new class of single-nucleotide editors, researchers can target the most common type of pathogenic SNP in humans.

1 Comment

image: FDA Approves Second CAR T-Cell Therapy

FDA Approves Second CAR T-Cell Therapy

By Ashley P. Taylor | October 19, 2017

The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas. 

0 Comments

A new study identifies microorganisms residing in the human fallopian tubes and uterus, but some researchers are skeptical of the findings. 

0 Comments

image: Compound Found in Red Wine Boosts Immune Cell Function

Compound Found in Red Wine Boosts Immune Cell Function

By Catherine Offord | October 17, 2017

At low doses, resveratrol enhanced human T-cell activity in vitro, while at high doses it interfered with cell signaling. 

0 Comments

image: Cancers Relapse by Feeding Off Immune Signals

Cancers Relapse by Feeding Off Immune Signals

By Shawna Williams | October 16, 2017

In mice, the tumor cells are able to thwart the immune response that would kill them—but immunotherapy prevented the return of melanoma.

0 Comments

image: Opinion: Microbiology Needs More Math

Opinion: Microbiology Needs More Math

By Mikhail Tikhonov | October 12, 2017

Empirical data and humans’ biased interpretations can only get so far in truly understanding life at the microscale.

2 Comments

image: Cesarean Section Results in Heavier Mouse Pups

Cesarean Section Results in Heavier Mouse Pups

By Ashley Yeager | October 11, 2017

Vaginal birth leads to changes in the development of offsprings’ microbiomes not seen among mice born via C-section, which researchers suspect might contribute to the weight differences.

0 Comments

image: Plague Ravaging Madagascar

Plague Ravaging Madagascar

By Kerry Grens | October 10, 2017

Nearly four dozen people have died.

0 Comments

image: Contributors

Contributors

By Aggie Mika | October 1, 2017

Meet some of the people featured in the October 2017 issue of The Scientist.

0 Comments

image: Damage Patroller

Damage Patroller

By Anna Azvolinsky | October 1, 2017

Stephen Elledge has built a career studying how eukaryotic cells maintain genomic integrity.

0 Comments

Popular Now

  1. Stem Cell Vaccine Protects Mice From Cancer
  2. Nobel Prize–Winning Biologist Dies
  3. Sci-Hub Loses Domains and Access to Some Web Services
  4. CDC: Flu Vaccine 36 Percent Effective So Far
AAAS